Pleiotropic Effects of Statins on the Cardiovascular System

Cited by (1,000)

Items 401–500 of 1,000

1. Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs
   Katarzyna Regulska, Miłosz Regulski, Bartosz Karolak, Marcin Michalak, Marek Murias, Beata Jadwiga Stanisz · 2019 · Pharmacological Research
2. Statin Use May Be Associated With Reduced Active Tuberculosis Infection: A Meta-Analysis of Observational Studies
   Xiaofei Li, Lina Sheng, Lanqing Lou · 2020 · Frontiers in Medicine
3. A brief overview of currently used atherosclerosis treatment approaches targeting lipid metabolism alterations.
   Anastasia Vladimirovna Poznyak, Dongwei Zhang, Varvara Alexandrovna Orekhova, Andrey V. Grechko, Reinhard Wetzker, Alexander Nikolaevich Orekhov · 2020 · PubMed Central
4. Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy
   Ingrid E.C. Verhaart, Ornella Cappellari, Christa L. Tanganyika-de Winter, Jaap J. Plomp, Sofia Nnorom, Kim E. Wells, John C. W. Hildyard, David Bull, Annemieke M Aartsma-Rus, Dominic J. Wells · 2020 · Journal of Neuromuscular Diseases
5. [18F]Atorvastatin Pharmacokinetics and Biodistribution in Healthy Female and Male Rats
   Gonçalo S. Clemente, Ines Farinha Antunes, Jürgen W. A. Sijbesma, Aren van Waarde, Adriaan A. Lammertsma, Alexander S. S. Dömling, Philip H. Elsinga · 2021 · Molecular Pharmaceutics
6. Undertreatment or Overtreatment With Statins: Where Are We?
   Irene García-Fernández-Bravo, Ana Torres-Do-Rego, Antonio José López-Farré, Francisco Galeano Valle, Pablo Demelo Rodríguez, Luis Antonio Alvarez-Sala-Walther · 2022 · Frontiers in Cardiovascular Medicine
7. Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry
   Carmine Siniscalchi, Behnood Bikdeli, David Jiménez, José María Suriñach, Pablo Demelo Rodríguez, Farès Moustafa, Aída Gil‐Díaz, Alberto García‐Ortega, My Bui, Manuel Monréal · 2024 · Thrombosis Research
8. Atorvastatin improved ulcerative colitis in association with gut microbiota-derived tryptophan metabolism
   Yidan Gou, Shijiao Cai, Yanyan Chen, Xiaoran Hou, Jing Zhang, Chong−Wen Bi, Peng Gu, Miao Yang, Hanxu Zhang, Weilong Zhong et al. · 2024 · Life Sciences
9. A revised systematic review and meta‐analysis on the effect of statins on D‐dimer levels
   Suzanne Schol‐Gelok, Francesca Morelli, Lidia R. Arends, Eric H. Boersma, Marieke J.H.A. Kruip, Jorie Versmissen, Teun van Gelder · 2019 · European Journal of Clinical Investigation
10. Effect of statin on life prognosis in Japanese patients undergoing hemodialysis
    Yuki Ota, Mineaki Kitamura, Kumiko Muta, Hiroshi Yamashita, Tadashi Uramatsu, Yoko Obata, Takashi Harada, Satoshi Funakoshi, Hiroshi Mukae, Tomoya Nishino · 2019 · PLoS ONE
11. Statins and Cardiomyocyte Metabolism, Friend or Foe?
    Tim Somers, Sailay Siddiqi, Wim J. Morshuis, Frans G. M. Rüssel, Tom J.J. Schirris · 2023 · Journal of Cardiovascular Development and Disease
12. Phytol from Scoparia dulcis prevents NF-κB-mediated inflammatory responses during macrophage polarization
    Parimalanandhini Duraisamy, Angusamy Annapoorani, Sangeetha Ravi, Mahalakshmi Krishnan, Livya Catherene Martin, Beulaja Manikandan, Sundaram Janarthanan, Manikandan Ramar · 2024 · 3 Biotech
13. EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation
    Carles Tolosa, Enric Cascos, Luis Gerardo Rodríguez‐Lobato, Alexandra Pedraza, María Suárez‐Lledó, Paola Andrea Charry, María Teresa Solano, Julia Martínez-Sánchez, Joan Cid, Miquel Lozano et al. · 2024 · Bone Marrow Transplantation
14. Role of Trimetazidine in Ameliorating Endothelial Dysfunction: A Review
    Yusof Kamisah, Hamat Hamdi Che Hassan · 2024 · Pharmaceuticals
15. Beyond low-density lipoprotein cholesterol levels: Impact of prior statin treatment on ischemic stroke outcomes
    Zimo Chen, Jinglin Mo, Kaixuan Yang, Yingyu Jiang, Chunjuan Wang, Xin Nian Yang, Yong Jiang, Xia Meng, Jie Xu, Hao Li et al. · 2024 · The Innovation
16. Prospects for Diminishing the Impact of Nonamyloid Small-Vessel Diseases of the Brain
    Anne Joutel · 2019 · The Annual Review of Pharmacology and Toxicology
17. Low total cholesterol is associated with increased major adverse cardiovascular events in men aged ≥70 years not taking statins
    Sonali Rukshana Gnanenthiran, Austin C. C. Ng, Robert Graham Cumming, David B. Brieger, David George Le Couteur, Louise M. Waite, David J. Handelsman, Vasi Naganathan, Leonard Kritharides, Fiona Blyth · 2019 · Heart
18. State of the Art: Therapie mit Statinen
    Ulrich Laufs, Oliver Weingärtner, Ursula Kassner, Ulrike Schatz · 2021 · DMW - Deutsche Medizinische Wochenschrift
19. Virtual Screening of Novel 24-Dehydroxysterol Reductase (DHCR24) Inhibitors and the Biological Evaluation of Irbesartan in Cholesterol-Lowering Effect
    Haozhen Wang, Ziyin Lu, Yang Li, Ting Liu, Linlin Zhao, Tianqi Gao, Xiuli Lu, Bing Gao · 2023 · Molecules
20. Polypill-based strategy vs. usual care for secondary prevention of cardiovascular disease: a meta-analysis of randomized controlled trials
    André Rivera, Bruno Campos, Stephanie Ceolin, Amanda Godoi, Everton Bruno Castanha, Carlos Alberto Campello Jorge, Rhanderson N. Cardoso · 2023 · European Journal of Preventive Cardiology
21. Effects of Simvastatin Beyond Dyslipidemia: Exploring Its Antinociceptive Action in an Animal Model of Complex Regional Pain Syndrome-Type I
    Graziela Cleuza Vieira, Juliana Cavalli, Elaine Cristina Dalazen Gonçalves, Tainara R. Gonçalves, Larissa R. Laurindo, Maíra Cola, Rafael Cypriano Dutra · 2017 · Frontiers in Pharmacology
22. Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis
    Anubodh Sunny Varshney, David E. Wang, Ankeet S. Bhatt, Alexander J. Blood, Musa A. Sharkawi, Hasan Khalid Siddiqi, Muthiah Vaduganathan, Peter Philip Monteleone, Manesh R. Patel, W. Schuyler Jones et al. · 2020 · American Heart Journal
23. The impact of lipid-lowering medications on coronary artery plaque characteristics
    Vishnu Priya Pulipati, Francis J. Alenghat · 2021 · American Journal of Preventive Cardiology
24. Association between statin use and Parkinson's disease in Korean patients with hyperlipidemia
    Ji Hee Kim, In Bok Chang, Yoo Hwan Kim, Mi Jung Kwon, Joo‐Hee Kim, Hyo Geun Choi · 2022 · Parkinsonism & Related Disorders
25. Efficacy and Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors as Adjuvant Treatments for Patients with Hypercholesterolemia Treated with Statin: A Systematic Review and Network Meta-analysis
    Yi-Ting Huang, Li‐Ting Ho, Hsin‐Yin Hsu, Yu‐Kang Tu, Kuo‐Liong Chien · 2022 · Frontiers in Pharmacology
26. Kawasaki Disease-like Vasculitis Facilitates Atherosclerosis, and Statin Shows a Significant Antiatherosclerosis and Anti-Inflammatory Effect in a Kawasaki Disease Model Mouse
    Yusuke Motoji, Ryuji Fukazawa, Ryosuke Matsui, Noriko Nagi‐Miura, Yasuo Miyagi, Yasuhiko Itoh, Yôsuke Ishii · 2022 · Biomedicines
27. Expression of ICAM-1 and E-selectin in different metabolic obesity phenotypes: discrepancy for endothelial dysfunction
    Menghui Liu, Panpan Wang, Pengxin Xie, X. Xu, Lixiang He, X. Chen, S Zhang, Yifen Lin, Yining Huang, Wenhao Xia et al. · 2023 · Journal of Endocrinological Investigation
28. Oxidized Low‐Density Lipoprotein (Ox‐LDL)‐Triggered Double‐Lock Probe for Spatiotemporal Lipoprotein Oxidation and Atherosclerotic Plaque Imaging
    Xu Zhi, Yufen Sun, Fangjian Cai, Sisi Wang, Hu Gao, Fan Yu Wu, Lei Zhang, Zhen Shen · 2023 · Advanced Healthcare Materials
29. A novel circular RNA, circSQSTM1, protects the endothelial function in atherosclerosis
    Ziqi Chen, Ruoyu Wang, Yinghong Zhu, Ziyao Huang, Xuewen Yang, Qiushi Li, Meijun Zhong, Wei Zhang, Lin Chen, Wei Wu et al. · 2023 · Free Radical Biology and Medicine
30. Evolving Clinical–Translational Investigations of Cerebroprotection in Ischemic Stroke
    Yinghui Li, Laurel E. Schappell, Claire Polizu, James DiPersio, Stella E. Tsirka, Marc W. Halterman, Neil A. Nadkarni · 2023 · Journal of Clinical Medicine
31. Assessing the relationship between lipoprotein(a) levels and blood pressure among hypertensive patients beyond conventional measures. An observational study
    Néstor Vázquez-Agra, Antón Cruces‐Sande, Sofía Gouveia, Jose-Enrique Lopez-Paz, Miguel Camafort, Emilio Casariego-Vales, Antonio Pose‐Reino, Á. Hermida Ameijeiras · 2024 · Scientific Reports
32. Reactive Oxygen Species-Responsive Chitosan–Bilirubin Nanoparticles Loaded with Statin for Treatment of Cerebral Ischemia
    Raveena Nagareddy, Jahae Kim, Jihye Kim, Reju George Thomas, Kang‐Ho Choi, Yong‐Yeon Jeong · 2024 · Biomaterials Research
33. Biochemical targets of drugs mitigating oxidative stress via redox-independent mechanisms
    Bernd Gesslbauer, Valery N. Bochkov · 2017 · Biochemical Society Transactions
34. Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study
    Jiunn‐Horng Kang, Li‐Ting Kao, Herng‐Ching Lin, Ta-Jung Wang, Tsung-Yeh Yang · 2018 · PLoS ONE
35. Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia
    Robert G. Krysiak, Witold Szkróbka, Bogusław Okopień · 2018 · The Journal of Clinical Pharmacology
36. An updated review of lipid‐modifying therapy
    Leon A. Simons · 2019 · The Medical Journal of Australia
37. Atorvastatin and pravastatin stimulate nitric oxide and reactive oxygen species generation, affect mitochondrial network architecture and elevate nicotinamide N‐methyltransferase level in endothelial cells
    Dorota Dymkowska, Antoni Wrzosek, Krzysztof Zabłocki · 2020 · Journal of Applied Toxicology
38. Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?
    Hyun-Eui Park, Wonsik Lee, Min‐Kyoung Shin, Sung Jae Shin · 2021 · Frontiers in Immunology
39. Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence
    Josip A. Borovac, Mette Leth-Olsen, Marko Kumrić, Domenico D’Amario, Konstantin Schwarz, Duška Glavaš, Joško Božić · 2021 · European Journal of Clinical Pharmacology
40. Statins Show Anti-Atherosclerotic Effects by Improving Endothelial Cell Function in a Kawasaki Disease-like Vasculitis Mouse Model
    Yusuke Motoji, Ryuji Fukazawa, Ryosuke Matsui, Yoshinori Abe, Ikuno Uehara, Makoto Watanabe, Yoshiaki Hashimoto, Yasuo Miyagi, Noriko Nagi‐Miura, Nobuyuki Tanaka et al. · 2022 · International Journal of Molecular Sciences
41. Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
    Christopher LaFratte, Samuel K. Peasah, Yan Huang, Deanne L. Hall, Urvashi B. Patel, Chester B. Good · 2023 · Journal of the American Heart Association
42. Impact of von Willebrand factor on coronary plaque burden in coronary artery disease patients treated with statins
    Yuta Kato, Atsushi Iwata, Makito Futami, Motoki Yamashita, Satoshi Imaizumi, Takashi Kuwano, Amane Ike, Makoto Sugihara, Hiroaki Nishikawa, Bo Zhang et al. · 2018 · Medicine
43. No effect of PCSK9 inhibitors on D-dimer and fibrinogen levels in patients with familial hypercholesterolemia
    Suzanne Schol‐Gelok, J.M.H. Galema-Boers, Teun van Gelder, Marieke J.H.A. Kruip, Jeanine E. Roeters van Lennep, Jorie Versmissen · 2018 · Biomedicine & Pharmacotherapy
44. Overexpression of FNTB and the activation of Ras induce hypertrophy and promote apoptosis and autophagic cell death in cardiomyocytes
    Jie Ding, Yu X. Chen, Yan Chen, Yun Mou, Xiao T. Sun, Dongpu Dai, Chen Z. Zhao, Jian Yang, Shen Hu, Xiaogang Guo · 2020 · Journal of Cellular and Molecular Medicine
45. Beneficial anti-inflammatory effects of combined rosuvastatin and cilostazol in a TNF-driven inflammatory model
    Okki Cho, You-Jin Jang, Kyung‐Yeon Park, Tae‐Hwe Heo · 2018 · Pharmacological Reports
46. Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis
    Ke An, Rong Huang, Sai Tian, Dan Guo, Jiaqi Wang, Hongyan Lin, Shaohua Wang · 2019 · Lipids in Health and Disease
47. Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention
    Norihito Takahashi, Tomotaka Dohi, Hirohisa Endo, Takehiro Funamizu, Hideki Wada, Shinichiro Doi, Yoshiteru Kato, Manabu Ogita, Iwao Okai, Hiroshi Iwata et al. · 2020 · Journal of Clinical Medicine
48. Pre-Stroke Statin Therapy Improves In-Hospital Prognosis Following Acute Ischemic Stroke Associated with Well-Controlled Nonvalvular Atrial Fibrillation
    Paweł Wańkowicz, Jacek Staszewski, Aleksander Dȩbiec, Marta Małgorzata Nowakowska-Kotas, Aleksandra Szylińska, Agnieszka Turoń-Skrzypińska, Iwona Rotter · 2021 · Journal of Clinical Medicine
49. Could Statin Therapy Be Useful in Patients With Coronavirus Disease 2019 (COVID-19)?
    José David Torres-Peña, Niki Katsiki, Pablo Pérez‐Martínez · 2021 · Frontiers in Cardiovascular Medicine
50. Combined Therapy with Simvastatin- and Coenzyme-Q10-Loaded Nanoparticles Upregulates the Akt-eNOS Pathway in Experimental Metabolic Syndrome
    Ezgi Şaman, Martina Cebová, Andrej Barta, M. Koneracká, Vlasta Závišová, Anita Eckstein Andicsová, Martin Danko, Jaroslav Mosnáček, Oľga Pecháňová · 2022 · International Journal of Molecular Sciences
51. Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data
    Robert J. Cubeddu, Shannon Murphy, Craig R. Asher, Santiago García, Juan F. Granada, Creighton W. Don, Sankalp P. Patel, Mazen Saadi Albaghdadi, João L. Cavalcante, Megan J. Coylewright et al. · 2022 · American Heart Journal
52. Augmented oxidative stress, accumulation of DNA damage and impaired DNA repair mechanisms in thrombotic primary antiphospholipid syndrome
    Maria Belen Pappa, Panagiotis A. Ntouros, Christina Papanikolaou, Petros Paul Sfikakis, Vassilis L. Souliotis, Maria G. Tektonidou · 2023 · Clinical Immunology
53. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms
    Hans Carl Hasselbalch, Peter Junker, Vibe Skov, Lasse Kjær, Trine Alma Knudsen, Morten Kranker Larsen, Morten Orebo Holmström, Mads Hald Andersen, Christina Jensen, M.A. Karsdal et al. · 2023 · Cancers
54. Calpain and Cardiometabolic Diseases
    Takuro Miyazaki · 2023 · International Journal of Molecular Sciences
55. Role of CETP, PCSK-9, and CYP7-alpha in cholesterol metabolism: Potential targets for natural products in managing hypercholesterolemia
    Rita Ngozi Aguchem, Innocent Uzochukwu Okagu, Ekezie Matthew Okorigwe, Jude Obiorah Uzoechina, Stephen Chukwubuikem Nnemolisa, Timothy Prince Chidike Ezeorba · 2024 · Life Sciences
56. Drug Delivery to the brain: How Can Nanoencapsulated Statins Be Used in the Clinic?
    Fabio Sonvico, Francesca Zimetti, Adriana Raffin Pohlmann, Sı́lvia Stanisçuaski Guterres · 2017 · Therapeutic Delivery
57. Recent Advances in Understanding the Pathogenesis of Cardiovascular Diseases and Development of Treatment Modalities
    Rahul Mittal, Vasanti M. Jhaveri, Sae-In Samantha Kay, Aubrey B. Greer, Kyle J. Sutherland, Hannah Stowe McMurry, Nicole Lin, Jeenu Mittal, Arul K. Malhotra, Amit P. Patel · 2018 · Cardiovascular & Haematological Disorders - Drug Targets
58. Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: Evidence for an endothelium-independent mechanism
    Mais Absi, Basma Ghazi Eid, Nick Ashton, George Hart, Alison M. Gurney · 2019 · PLoS ONE
59. Deconvoluting the biology and druggability of protein lipidation using chemical proteomics
    Ana Losada de la Lastra, Sarah Hassan, Edward W. Tate · 2020 · Current Opinion in Chemical Biology
60. Targeting the Cholesterol Paradigm in the Risk Reduction for Atherosclerotic Cardiovascular Disease: Does the Mechanism of Action of Pharmacotherapy Matter for Clinical Outcomes?
    Ruihai Zhou, George A. Stouffer, Sidney C. Smith · 2021 · Journal of Cardiovascular Pharmacology and Therapeutics
61. Chronic Thoracic Aortic Dissection: How to Treat, When to Intervene
    Panteleimon Ε. Papakonstantinou, Dimitra Benia, Dimitrios Polyzos, Κωνσταντίνος Παπακωνσταντίνου, Filippos‐Paschalis Rorris, Fotios Toulgaridis, Konstantinos Manousiadis, Sotirios Xydonas, Antonios Sideris · 2022 · Life
62. Role of Lipid-Lowering and Anti-Inflammatory Therapies on Plaque Stabilization
    Krzysztof L. Bryniarski, Wijnand K. den Dekker, Jacek Legutko, Paweł M. Gąsior, Jeroen Tahon, Roberto Diletti, Jeroen Wilschut, Rutger-Jan M. Nuis, Joost Daemen, Paweł Kleczyński et al. · 2024 · Journal of Clinical Medicine
63. A transcriptomic model to predict increase in fibrous cap thickness in response to high-dose statin treatment: Validation by serial intracoronary OCT imaging
    Kipp W. Johnson, Benjamin Scott Glicksberg, Khader Shameer, Yuliya Vengrenyuk, Chayakrit Krittanawong, Adam J. Russak, Samin Kumar Sharma, Jagat Narula, Joel T. Dudley, Annapoorna Subhash Kini · 2019 · EBioMedicine
64. Impact of lipophilic vs hydrophilic statins on the clinical outcome and biomarkers of remodelling in heart failure patients: A prospective comparative randomized study
    Nouran Omar El Said, Lamia Mohamed El Wakeel, Hazem Mohamed Khorshid, Ebtissam Abdel Ghaffar Darweesh, Marwa Adel Ahmed · 2020 · British Journal of Clinical Pharmacology
65. Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention
    Imma Forzano, Domenico Florimonte, Viviana Narciso, Mario Enrico Canonico, Domenico Simone Castiello, Lina Manzi, Stefano Cristiano, Alessandra Maria Spinelli, Donato Maria Vallone, Dario D’Alconzo et al. · 2025 · Journal of Clinical Medicine
66. RETRACTED: Rho-Kinase inhibitors ameliorate diclofenac-induced cardiotoxicity in chloroquine-treated adjuvant arthritic rats
    Manar Hamed Arafa, Nanies Sameeh Mohammad, Hebatallah Husseini Atteia · 2020 · Life Sciences · Retracted
67. The rationale for the treatment of long-Covid symptoms – A cardiologist's view
    Elisabeth Schieffer, Bernhard Schieffer · 2022 · Frontiers in Cardiovascular Medicine
68. Di-(2-ethylhexyl) Phthalate Limits the Lipid-Lowering Effects of Simvastatin by Promoting Protein Degradation of Low-Density Lipoprotein Receptor: Role of PPARγ-PCSK9 and LXRα-IDOL Signaling Pathways
    Bei‐Chia Guo, Ko‐Lin Kuo, Jenq‐Wen Huang, Chia-Hui Chen, Der‐Cherng Tarng, Tzong‐Shyuan Lee · 2023 · Antioxidants
69. Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
    Baihan Zeng, Luming Qi, Sha Wu, Nannan Liu, Jie Wang, Kaidi Nie, Lina Xia, Shuguang Yu · 2023 · Journal of Visualized Experiments
70. Statin Use and Stroke Rate in Older Adults With Atrial Fibrillation: A Population‐Based Cohort Study
    Bisan Shweikialrefaee, Dennis T. Ko, Jiming Fang, Andrea Pang, Peter C. Austin, Paul Dorian, Sheldon M. Singh, Cynthia Anne Jackevicius, Karen Tu, Douglas S. Lee et al. · 2023 · Journal of the American Heart Association
71. Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross‐sectional analysis from the MS‐STAT2 randomized controlled trial
    Thomas E. Williams, Nevin A. John, Alberto Calvi, Alessia Bianchi, Floriana De Angelis, Anisha Doshi, Sarah L Wright, Madiha Shatila, Marios C. Yiannakas, Fatima Chowdhury et al. · 2023 · European Journal of Neurology
72. Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults
    Da Hea Seo, Yujin Jeong, Yongin Cho, So Hun Kim, Seongbin Hong, Young Ju Suh, Seong Hee Ahn · 2023 · Osteoporosis International
73. Platelets as Potential Non-Traditional Cardiovascular Risk Factor—Analysis Performed in Healthy Donors
    Patrycja Szymańska, Bogusława Luzak, Przemysław Siarkiewicz, Jacek Golański · 2023 · International Journal of Molecular Sciences
74. Lipid rafts disruption by statins negatively impacts the interaction between SARS-CoV-2 S1 subunit and ACE2 in intestinal epithelial cells
    Marianne El Khoury, Hassan Y. Naim · 2024 · Frontiers in Microbiology
75. Statin therapy and cardiovascular protection in type 2 diabetes: The role of baseline LDL-Cholesterol levels. A systematic review and meta-analysis of observational studies
    Negin Soroush, Mitra Nekouei Shahraki, Soroush Mohammadi Jouabadi, Masoud Amiri, Elif Aribas, Bruno H. Ch. Stricker, Fariba Ahmadizar · 2024 · Nutrition Metabolism and Cardiovascular Diseases
76. Induction of let-7d-5p miRNA modulates aortic smooth muscle inflammatory signaling and phenotypic switching
    Tanwi Vartak, Elena Giardini, Daniel John Kelly, Bruce Moran, Ciarán Kennedy, Mary Claire Barry, Catherine Godson, Eoin Patrick Brennan · 2024 · Atherosclerosis
77. The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
    Gurparneet Kaur Sohi, Naba Farooqui, Arjunmohan Mohan, Kamalnath Sankaran Rajagopalan, Xing Li, Xiang yang Zhu, Kyra L. Jordan, James D. Krier, Ishran M. Saadiq, Hui Jun Tang et al. · 2024 · Stem Cell Research & Therapy
78. A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance database
    Zhuohui Chen, Xiang Wang, Ziwei Teng, Jing Huang, Jianzhong Mo, Chunrun Qu, Yinghua Wu, Zhixiong Liu, Fangkun Liu, Kun Xia · 2024 · EBioMedicine
79. Early statin use is associated with improved survival and cardiovascular outcomes in patients with atrial fibrillation and recent ischaemic stroke: A propensity-matched analysis of a global federated health database
    Sylvia E. Choi, Tommaso Bucci, Jiayi Huang, Kai‐Hang Yiu, Christopher Tze‐Wei Tsang, Kui Kai Lau, Andrew M. Hill, Greg J Irving, Gregory Y.H. Lip, Azmil H. Abdul‐Rahim · 2024 · European Stroke Journal
80. Cardioprotective cytokine interleukin‐33 is up‐regulated by statins in human cardiac tissue
    Richard Pentz, Christoph Kaun, Barbara Thaler, Stefan Stojković, Max W. Lenz, Konstantin Alexander Krychtiuk, Andreas Oliver Zuckermann, Kurt Huber, Johann Wojta, Philipp J. Hohensinner et al. · 2018 · Journal of Cellular and Molecular Medicine
81. Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study
    Kyoung Im Cho, Bo Hyun Kim, Yong Hyun Park, Jeong-Cheon Ahn, Sang‐Hyun Kim, Wook‐Jin Chung, Weon Kim, Il Suk Sohn, Jinho Shin, Yong Jin Kim et al. · 2019 · Clinical Therapeutics
82. Hydroxychloroquine as a Preventive and Therapeutic Option in Preeclampsia – a Literature Review
    Daniela Deharde, Walter Klockenbusch, Ralf Schmitz, Marcus Brand, Helen Ann Köster, Kathrin Oelmeier de Murcia · 2020 · Geburtshilfe und Frauenheilkunde
83. Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
    Juan Cuauhtémoc Díaz-Zagoya, Alejandro Marín-Medina, Alma M. Zetina‐Esquivel, Jorge L. Blé‐Castillo, Andrés Eliú Castell-Rodríguez, Isela E. Juárez‐Rojop, Rodrigo Miranda‐Zamora · 2021 · Scientific Reports
84. Relationship Between Blood Lipid Levels and Mortality in Hospitalized COVID-19 Patients
    Sidar Şiyar Aydın, Emrah Aksakal, Faruk Aydınyılmaz, Oktay Gülcü, İbrahim Saraç, Kamuran Kalkan, Selim Aydemir, Remziye Doğan, Uğur Aksu, İbrahi̇m Hali̇l Tanboğa · 2022 · Angiology
85. The Frequency Of Rs2231142 in ABCG2 Among Native Hawaiian nd Pacific Islander Subgroups: Implications for Personalized Rosuvastatin Dosing
    Ola AlAzzeh, Youssef Malak Roman · 2023 · Pharmacogenomics
86. PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk
    Pere Rehues, Josefa Girona, Montse Guardiola, Núria Plana, Roberto Scicali, Salvatore Piro, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Lluís Recasens, Marta Pinyol et al. · 2023 · International Journal of Molecular Sciences
87. Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance
    Zsuzsanna Schelz, Hiba Faroug Muddather, István Zupkó · 2023 · Antibiotics
88. Moderate-dose simvastatin therapy potentiates the effect of vitamin D on thyroid autoimmunity in levothyroxine-treated women with Hashimoto’s thyroiditis and vitamin D insufficiency
    Robert G. Krysiak, Witold Szkróbka, Bogusław Okopień · 2017 · Pharmacological Reports
89. Distinct contribution of Rac1 expression in cardiomyocytes to anthracycline-induced cardiac injury
    Christian Henninger, Stephanie Pohlmann, Verena Ziegler, Jan Ohlig, Joachim P. Schmitt, Gerhard Fritz · 2019 · Biochemical Pharmacology
90. Creatine as a Candidate to Prevent Statin Myopathy
    Maurizio Balestrino, Enrico Adriano · 2019 · Biomolecules
91. Management of Hyperlipidemia After Stroke
    Daniel C. Brooks, Joseph Schindler · 2019 · Current Treatment Options in Cardiovascular Medicine
92. Statins reduce new-onset atrial fibrillation after acute myocardial infarction
    Chien-Hao Tseng, Wen-Jung Chung, Chen-Yu Li, Tzu‐Hsien Tsai, Chien‐Ho Lee, Shu‐Kai Hsueh, Chia‐Chen Wu, Cheng‐I Cheng · 2020 · Medicine
93. How I Treat statin-associated Side Effects in an Outpatient Setting
    Vishnu Priya Pulipati, Michael H. Davidson · 2021 · Future Cardiology
94. Effects of renin–angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation
    Ulrich Fischer‐Rasokat, Celine Bänsch, Matthias Renker, Andreas Rolf, Efstratios I. Charitos, Maren Weferling, Christoph Liebetrau, Eva Maria Herrmann, Yeong‐Hoon Choi, Christian W. Hamm et al. · 2022 · European Heart Journal - Cardiovascular Pharmacotherapy
95. Fusobacteriumnucleatum: Pathophysiological and Clinical Involvement in Inflammatory Bowel Diseases, Colorectal Cancer and Cardiovascular Diseases
    Vincenzo Quagliariello, Pietro Forte, Giuliana Ciappina, Luigi Colarusso, Carlotta Giorgi, Francesco Fiorica, Antonio Bottari, Giordana Di Mauro, Nicola Maurea, Massimiliano Berretta · 2025 · Cancers
96. Statins for Cardiac and Vascular Protection During and After Cancer Therapy
    Emily M. Heiston, William Gregory Hundley · 2022 · Current Oncology Reports
97. Intravenous thrombolysis for mild stroke: NIHSS 3–5 Versus NIHSS 0–2
    Liyuan Wang, Guangshuo Li, Yahui Hao, Manjun Hao, Yunyun Xiong · 2023 · Journal of Stroke and Cerebrovascular Diseases
98. The real-world data of lipid-lowering treatment in patients with peripheral artery disease and its association with severity of disease
    Hiroyoshi Komai, Masatsune Ogura, Hideki Sakashita, Noriyuki Miyama, Nobuko Yamamoto, Kanako Takai, Atsutoshi Hatada, Nobuhiro Tanimura, Takashi Nakamura, Masato Yoshida et al. · 2023 · Journal of Cardiology
99. Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis
    Saikun Wang, Ruiting Zhu, Chengwei Zhang, Yingze Guo, Mengjiao Lv, Changyue Zhang, Ce Bian, Ruixue Jiang, Wei Zhou, Lirong Guo · 2023 · PLoS ONE
100. Effect of adding PCSK9 inhibitors to lipid‐lowering interventions on arterial stiffness: A systematic review and meta‐analysis
     Iván Cavero‐Redondo, Nerea Moreno-Herráiz, Alicia Saz‐Lara, Iris Otero-Luis, Jose Ignacio Recio-Rodriguez, Alicia Saz‐Lara · 2024 · European Journal of Clinical Investigation